Today 200 scientists meet in Rome at the EU conference on “The Role of Research in Combating Antibiotic Resistance". It was organised by the European Commission together with the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Antibiotics, once hailed as a panacea to combat bacterial infections, seem to be more and more ineffective. The human body is responding less and less to antibiotics. New, more dangerous diseases, stubbornly resisting their power, are developing. The aim of the conference is to identify future research priorities to tackle the problem of anti-bacterial resistance and human health, addressing both basic and clinical research. At the same time, the Commission is announcing that it will invest € 6 million to support two major research projects in this field, with a total project budget of €12.6 million from the first call for proposals in the Sixth Research Framework Programme (2002-2006). One of these projects looks into resistance to the major class of antibiotics in clinical use, while the other project investigates basic molecular mechanisms of resistance. The projects are being negotiated and will start in a few weeks after signing of contracts.
"People trust antibiotics to cure almost any kind of disease: unfortunately, as recent outbreaks of Severe Acute Respiratory Syndrome (SARS) show, this is not the case,” says European Research Commissioner Philippe Busquin. “Antibiotic resistance is therefore the focus of research within the EU scientific funding programmes. More research for the benefit of patients is needed to make use of the wealth of information provided by more than 140 bacterial genomes known today. We must also make sure that the pharmaceutical industry continues its research into the development of new antibiotics. With more than €100 million invested by the EU over the last four years in this field, we have supported more than 80 research projects on antimicrobial resistance. We will keep up the fight to find innovative answers to this problem. ”
Once "wonder drugs" ineffective today
Fabio Fabbi | European Commission
Lung images of twins with asthma add to understanding of the disease
06.12.2019 | University of Western Ontario
Between Arousal and Inhibition
06.12.2019 | Albert-Ludwigs-Universität Freiburg im Breisgau
University of Texas and MIT researchers create virtual UAVs that can predict vehicle health, enable autonomous decision-making
In the not too distant future, we can expect to see our skies filled with unmanned aerial vehicles (UAVs) delivering packages, maybe even people, from location...
With ultracold chemistry, researchers get a first look at exactly what happens during a chemical reaction
The coldest chemical reaction in the known universe took place in what appears to be a chaotic mess of lasers. The appearance deceives: Deep within that...
Abnormal scarring is a serious threat resulting in non-healing chronic wounds or fibrosis. Scars form when fibroblasts, a type of cell of connective tissue, reach wounded skin and deposit plugs of extracellular matrix. Until today, the question about the exact anatomical origin of these fibroblasts has not been answered. In order to find potential ways of influencing the scarring process, the team of Dr. Yuval Rinkevich, Group Leader for Regenerative Biology at the Institute of Lung Biology and Disease at Helmholtz Zentrum München, aimed to finally find an answer. As it was already known that all scars derive from a fibroblast lineage expressing the Engrailed-1 gene - a lineage not only present in skin, but also in fascia - the researchers intentionally tried to understand whether or not fascia might be the origin of fibroblasts.
Fibroblasts kit - ready to heal wounds
Research from a leading international expert on the health of the Great Lakes suggests that the growing intensity and scale of pollution from plastics poses serious risks to human health and will continue to have profound consequences on the ecosystem.
In an article published this month in the Journal of Waste Resources and Recycling, Gail Krantzberg, a professor in the Booth School of Engineering Practice...
03.12.2019 | Event News
15.11.2019 | Event News
15.11.2019 | Event News
06.12.2019 | Earth Sciences
06.12.2019 | Life Sciences
06.12.2019 | Information Technology